Historical award
Spring Mill Pharma Incorporated
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (9 days old).
Fiscal year 2026: data through (9 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Current award value
- $25,044,892.75
- Potential award value
- $44,503,613.75
- Total obligated to date
- $25,044,892.75
Source date: Nov 9, 2026
Recorded work
NON BETA-LACTAM INHIBITORS OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Award activity
- Obligations in covered fiscal years
- $255,864.75
- Transactions in covered fiscal years
- 5
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_AWD_75N93020C00016_7529_-NONE-_-NONE-